These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1972345

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and regulation of retinoic acid receptors in human breast cancer cells.
    Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL.
    Cancer Res; 1992 Apr 15; 52(8):2236-42. PubMed ID: 1313739
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 11. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
    Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS.
    Mol Endocrinol; 1988 Mar 15; 2(3):263-71. PubMed ID: 3398853
    [Abstract] [Full Text] [Related]

  • 12. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 15; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 13. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.
    Oncogene; 2003 Oct 09; 22(44):6937-41. PubMed ID: 14534541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL.
    Cancer Res; 1993 Dec 15; 53(24):5940-5. PubMed ID: 8261407
    [Abstract] [Full Text] [Related]

  • 18. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V, Miodini P, Fioravanti L, Di Fronzo G.
    Anticancer Res; 1995 Dec 15; 15(6B):2551-5. PubMed ID: 8669822
    [Abstract] [Full Text] [Related]

  • 19. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.
    Endocr Relat Cancer; 2007 Sep 15; 14(3):691-702. PubMed ID: 17914099
    [Abstract] [Full Text] [Related]

  • 20. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K, Banerjee S, Saxena N, Banerjee SK.
    Int J Oncol; 2003 Mar 15; 22(3):609-14. PubMed ID: 12579315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.